TRIM28 mediates primer binding site-targeted silencing of Lys1,2 tRNA-utilizing retroviruses in embryonic cells

Area of Science:

• Molecular Biology
• Virology
• Genetics

Background:

• Embryonic cells restrict murine leukemia viruses (MLVs) via postintegration transcriptional silencing to prevent germline insertional mutagenesis.
• This silencing is mediated by a nuclear repression complex targeting proviral DNA's repressor-binding site, which overlaps the essential tRNA primer binding site.
• The cellular corepressor TRIM28 (Tripartite Motif-Containing Protein 28) was previously shown to be recruited to the proline tRNA primer binding site for MLV silencing.

Purpose of the Study:

• To investigate the role of TRIM28 in the restriction of retroviruses that utilize a different tRNA primer.
• To generalize the understanding of TRIM28's function in retroviral restriction beyond MLVs.

Main Methods:

• Analysis of retroviral transcriptional silencing mechanisms in embryonic cells.
• Investigation of TRIM28 recruitment and function in the context of different tRNA primer binding sites.
• Experimental validation of TRIM28's requirement for restricting retroviruses utilizing Lys-1,2 tRNA.

Main Results:

• TRIM28 is demonstrated to be essential for the restriction of retroviruses employing the Lys-1,2 tRNA for DNA synthesis priming.
• This finding extends the known function of TRIM28 in mediating transcriptional silencing to a distinct class of retroviruses.
• The results indicate that the TRIM28-mediated silencing system is not limited to proline tRNA-utilizing viruses.

Conclusions:

• TRIM28 plays a generalized role in the restriction of diverse retroviruses in embryonic cells.
• The findings suggest an evolved defense mechanism utilizing TRIM28 to safeguard the germline against multiple retroviral threats.
• This study broadens the scope of TRIM28's involvement in innate antiviral immunity.